167 related articles for article (PubMed ID: 34019284)
1. Methods of Expression, Purification, and Preparation of the c-Myc b-HLH-LZ for Its Biophysical Characterization.
Delattre P; Montagne M; Lavigne P
Methods Mol Biol; 2021; 2318():13-19. PubMed ID: 34019284
[TBL] [Abstract][Full Text] [Related]
2. New structural determinants for c-Myc specific heterodimerization with Max and development of a novel homodimeric c-Myc b-HLH-LZ.
Beaulieu ME; McDuff FO; Frappier V; Montagne M; Naud JF; Lavigne P
J Mol Recognit; 2012 Jul; 25(7):414-26. PubMed ID: 22733550
[TBL] [Abstract][Full Text] [Related]
3. Methods for the expression, purification, preparation, and biophysical characterization of constructs of the c-Myc and Max b-HLH-LZs.
Beaulieu ME; McDuff FO; Bédard M; Montagne M; Lavigne P
Methods Mol Biol; 2013; 1012():7-20. PubMed ID: 24006055
[TBL] [Abstract][Full Text] [Related]
4. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
Lavigne P; Crump MP; Gagné SM; Hodges RS; Kay CM; Sykes BD
J Mol Biol; 1998 Aug; 281(1):165-81. PubMed ID: 9680483
[TBL] [Abstract][Full Text] [Related]
5. Biophysical and Structural Methods to Study the bHLHZip Region of Human c-MYC.
Zinzalla G
Methods Mol Biol; 2021; 2318():21-43. PubMed ID: 34019285
[TBL] [Abstract][Full Text] [Related]
6. Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.
Maltais L; Montagne M; Bédard M; Tremblay C; Soucek L; Lavigne P
PLoS One; 2017; 12(3):e0174413. PubMed ID: 28350847
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis by the c-Myc helix-loop-helix/leucine zipper domain in mouse 3T3-L1 fibroblasts.
Kohlhuber F; Hermeking H; Graessmann A; Eick D
J Biol Chem; 1995 Dec; 270(48):28797-805. PubMed ID: 7499403
[TBL] [Abstract][Full Text] [Related]
8. The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.
Montagne M; Beaudoin N; Fortin D; Lavoie CL; Klinck R; Lavigne P
PLoS One; 2012; 7(2):e32172. PubMed ID: 22384171
[TBL] [Abstract][Full Text] [Related]
9. Miz-1 and Max compete to engage c-Myc: implication for the mechanism of inhibition of c-Myc transcriptional activity by Miz-1.
Bédard M; Maltais L; Montagne M; Lavigne P
Proteins; 2017 Feb; 85(2):199-206. PubMed ID: 27859590
[TBL] [Abstract][Full Text] [Related]
10. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic activity of the c-Myc protein requires dimerization with Max.
Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
Marchetti A; Abril-Marti M; Illi B; Cesareni G; Nasi S
J Mol Biol; 1995 May; 248(3):541-50. PubMed ID: 7752223
[TBL] [Abstract][Full Text] [Related]
13. The dimerization stability of the HLH-LZ transcription protein family is modulated by the leucine zippers: a CD and NMR study of TFEB and c-Myc.
Muhle-Goll C; Gibson T; Schuck P; Schubert D; Nalis D; Nilges M; Pastore A
Biochemistry; 1994 Sep; 33(37):11296-306. PubMed ID: 7727380
[TBL] [Abstract][Full Text] [Related]
14. Both the helix-loop-helix and the leucine zipper motifs of c-Myc contribute to its dimerization specificity with Max.
Davis LJ; Halazonetis TD
Oncogene; 1993 Jan; 8(1):125-32. PubMed ID: 8423990
[TBL] [Abstract][Full Text] [Related]
15. The Max homodimeric b-HLH-LZ significantly interferes with the specific heterodimerization between the c-Myc and Max b-HLH-LZ in absence of DNA: a quantitative analysis.
McDuff FO; Naud JF; Montagne M; Sauvé S; Lavigne P
J Mol Recognit; 2009; 22(4):261-9. PubMed ID: 19189276
[TBL] [Abstract][Full Text] [Related]
16. Direct visualization of the binding of c-Myc/Max heterodimeric b-HLH-LZ to E-box sequences on the hTERT promoter.
Lebel R; McDuff FO; Lavigne P; Grandbois M
Biochemistry; 2007 Sep; 46(36):10279-86. PubMed ID: 17705400
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of discrimination between cognate and non-specific DNA by dimeric b/HLH/LZ transcription factors.
Sauvé S; Naud JF; Lavigne P
J Mol Biol; 2007 Jan; 365(4):1163-75. PubMed ID: 17109882
[TBL] [Abstract][Full Text] [Related]
18. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
[TBL] [Abstract][Full Text] [Related]
19. Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.
Crouch DH; Fisher F; La Rocca SA; Goding CR; Gillespie DA
Nucleic Acids Res; 2005; 33(16):5235-42. PubMed ID: 16166655
[TBL] [Abstract][Full Text] [Related]
20. Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.
Jean-François N; Frédéric G; Raymund W; Benoit C; Lavigne P
J Mol Biol; 2003 Mar; 326(5):1577-95. PubMed ID: 12595267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
